Hongcheng Capital
Overview
Hongcheng Capital is a venture capital firm based in Nanchang, China, that invests in early and growth-stage companies. Its investment areas include biotechnology, pharmaceuticals, automotive, semiconductors, and logistics. The firm is known to have co-managed the "Hongcheng RMB Fund I", a 2015 vintage fund.
Portfolio Companies
2
Website
hongchengvc.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| IASO Bio | Jan 2023 | Series C Extension | - |
| Jiangsu Vcare Pharmatech Co., Ltd. | Dec 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hongcheng Capital based?
Hongcheng Capital is headquartered in Nanchang, Jiangxi, China.
When was Hongcheng Capital founded?
Founding year information for Hongcheng Capital is not publicly available.
How many portfolio companies does Hongcheng Capital have?
Hongcheng Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Hongcheng Capital's portfolio?
Portfolio companies visible on Caplight include IASO Bio, Jiangsu Vcare Pharmatech Co., Ltd..
What was Hongcheng Capital's most recent investment shown here?
Hongcheng Capital's most recent investment in this portfolio sample was in IASO Bio in 2023.
What sectors does Hongcheng Capital focus on?
Hongcheng Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Hongcheng Capital focus on?
Hongcheng Capital typically invests at the Mid stage.
What is Hongcheng Capital's AUM?
Hongcheng Capital's assets under management are estimated at over $1.1B.